Aspen Grove Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,146
| Closed | -$134K | – | 218 |
|
|
2024
Q2 | $134K | Sell |
10,146
-50
| -0.5% | -$659 | 0.03% | 201 |
|
|
2024
Q1 | $142K | Buy |
10,196
+86
| +0.9% | +$1.2K | 0.04% | 201 |
|
|
2023
Q4 | $144K | Buy |
+10,110
| New | +$144K | 0.04% | 184 |
|
|
2023
Q3 | – | Sell |
-10,310
| Closed | -$165K | – | 205 |
|
|
2023
Q2 | $165K | Sell |
10,310
-920
| -8% | -$14.7K | 0.05% | 185 |
|
|
2023
Q1 | $185K | Buy |
11,230
+1,078
| +11% | +$17.8K | 0.08% | 140 |
|
|
2022
Q4 | $158K | Buy |
+10,152
| New | +$158K | 0.07% | 152 |
|